JP2022503771A5 - - Google Patents

Info

Publication number
JP2022503771A5
JP2022503771A5 JP2021515655A JP2021515655A JP2022503771A5 JP 2022503771 A5 JP2022503771 A5 JP 2022503771A5 JP 2021515655 A JP2021515655 A JP 2021515655A JP 2021515655 A JP2021515655 A JP 2021515655A JP 2022503771 A5 JP2022503771 A5 JP 2022503771A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
treatment
paclitaxel
weight
composition according
Prior art date
Application number
JP2021515655A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022503771A (ja
JPWO2020084525A5 (https=
JP7518815B2 (ja
Filing date
Publication date
Priority claimed from IT102018000009731A external-priority patent/IT201800009731A1/it
Application filed filed Critical
Publication of JP2022503771A publication Critical patent/JP2022503771A/ja
Publication of JPWO2020084525A5 publication Critical patent/JPWO2020084525A5/ja
Publication of JP2022503771A5 publication Critical patent/JP2022503771A5/ja
Application granted granted Critical
Publication of JP7518815B2 publication Critical patent/JP7518815B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021515655A 2018-10-25 2019-10-23 筋層非浸潤性膀胱がんの治療におけるパクリタキセル-ヒアルロン酸複合体 Active JP7518815B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102018000009731 2018-10-25
IT102018000009731A IT201800009731A1 (it) 2018-10-25 2018-10-25 Coniugato paclitaxel - acido ialuronico nel trattamento del carcinoma vescicale non infiltrante
PCT/IB2019/059073 WO2020084525A1 (en) 2018-10-25 2019-10-23 Paclitaxel-hyaluronic acid conjugate in the treatment of non-muscle invasive bladder cancer

Publications (4)

Publication Number Publication Date
JP2022503771A JP2022503771A (ja) 2022-01-12
JPWO2020084525A5 JPWO2020084525A5 (https=) 2022-10-04
JP2022503771A5 true JP2022503771A5 (https=) 2022-10-04
JP7518815B2 JP7518815B2 (ja) 2024-07-18

Family

ID=65324453

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021515655A Active JP7518815B2 (ja) 2018-10-25 2019-10-23 筋層非浸潤性膀胱がんの治療におけるパクリタキセル-ヒアルロン酸複合体

Country Status (21)

Country Link
US (4) US20200397909A1 (https=)
EP (1) EP3870233B1 (https=)
JP (1) JP7518815B2 (https=)
KR (1) KR102913965B1 (https=)
CN (2) CN112805035A (https=)
CA (1) CA3112188A1 (https=)
DK (1) DK3870233T3 (https=)
EA (1) EA202190614A1 (https=)
ES (1) ES2971217T3 (https=)
FI (1) FI3870233T3 (https=)
HR (1) HRP20240188T1 (https=)
HU (1) HUE066288T2 (https=)
IT (1) IT201800009731A1 (https=)
LT (1) LT3870233T (https=)
MA (1) MA63879B1 (https=)
PL (1) PL3870233T3 (https=)
PT (1) PT3870233T (https=)
RS (1) RS65193B1 (https=)
SI (1) SI3870233T1 (https=)
SM (1) SMT202400021T1 (https=)
WO (1) WO2020084525A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000007747A1 (it) * 2020-04-10 2021-10-10 Fidia Farm Spa Coniugato acido ialuronico-paclitaxel nel trattamento del mesotelioma
IT202000008209A1 (it) * 2020-04-17 2021-10-17 Fidia Farm Spa Procedimento di sintesi di un coniugato acido ialuronico-paclitaxel

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0138572B1 (en) 1983-10-11 1990-07-25 FIDIA S.p.A. Hyaluronic acid fractions having pharmaceutical activity, methods for preparation thereof, and pharmaceutical compositions containing the same
IT1263393B (it) 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Processo per la preparazione e purificazione di acido ialuronico ad alto peso molecolare
NZ516873A (en) 2001-02-12 2003-11-28 Warner Lambert Co Compositions containing retinoids and erb inhibitors and their use in inhibiting retinoid skin damage
ITPD20020271A1 (it) 2002-10-18 2004-04-19 Fidia Farmaceutici Composti chimico-farmaceutici costituiti da derivati dei taxani legati covalentemente all'acido ialuronico o ai suoi derivati.
AR047938A1 (es) * 2003-08-25 2006-03-15 Combinatorx Inc Formulaciones, conjugados y combinaciones de farmacos para el tratamiento de neoplasmas
ITMI20071267A1 (it) 2007-06-22 2008-12-23 Fidia Farmaceutici Uso di coniugati dell'acido ialuronico nel trattamento locale di malattie cutanee iperproliferative
IT1402384B1 (it) 2010-09-09 2013-09-04 Fidia Farmaceutici Processo per la produzione di acido ialuronico in escherichia coli o bacillus megaterium
IT1402385B1 (it) 2010-09-09 2013-09-04 Fidia Farmaceutici Processo per la produzione di acido ialuronico in escherichia coli o bacillus subtilis
EP3290511B1 (en) 2011-11-09 2020-08-26 Spinalcyte, LLC Dermal fibroblasts for treatment of degenerative disc disease
IT201600079633A1 (it) 2016-07-28 2018-01-28 Fidia Farm Spa Procedimento di preparazione e purificazione del sale sodico dell’acido ialuronico
CN110859962B (zh) 2019-11-25 2021-01-22 山东大学 巴比妥酸衍生物修饰的二硫化钼二维纳米材料及其应用

Similar Documents

Publication Publication Date Title
CR20210563A (es) Compuestos y métodos para el tratamiento de covid-19
RU2010140682A (ru) Способ лечения пациента от инфекции, фармацевтическая композиция (варианты) и лекарственное средство
UY35624A (es) Uso de dosis elevadas de pridopidina para tratar la enfermedad de huntington
WO2006037031A3 (en) Formulations and methods for treatment of inflammatory diseases
JP2017525718A5 (https=)
JP2022188083A5 (https=)
RU2009110452A (ru) Галеновые составы алискирена
EA201492010A1 (ru) Применение высокой дозы лахинимода для лечения рассеянного склероза
JOP20220281A1 (ar) مركبات وتركيبات لتثبيط نشاط hif2 ألفا وطرق لاستخدامها
JP2022503771A5 (https=)
CL2024003616A1 (es) Composición farmacéutica oral y uso para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas.
JP2008520548A (ja) 薬剤耐性癌、薬剤耐性ウイルス感染症および薬剤耐性微生物感染症におけるノルジヒドログアヤレト酸誘導体の使用
JP2016512247A5 (https=)
JP2019507786A5 (https=)
FI3870233T3 (fi) Paklitakseli-Hyaluronihapon konjugaatti käytettäväksi ei-lihasinvasiivisen virtsarakon syövän hoidossa
JP2017537163A5 (https=)
RU2013105513A (ru) Производные 1-аминоалкилциклогексана для лечения воспалительных заболеваний кожи
JP2021102624A (ja) Cyr61及びvegf媒介性の状態の治療
CN102949387B (zh) 用于治疗单纯疱疹病毒的组合物和方法
JPWO2020084525A5 (https=)
JP2015515971A5 (https=)
RU2013127794A (ru) Фармацевтическая комбинация и композиция для лечения ожирения и ее применение
CA2469702A1 (en) Darifenacin for use in the treatment of urgency induced by overactive bladder
CY1113544T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει ενα συνδυασμο που σχηματιζεται απο τον αντιμικροβιακο παραγοντα σιπροφλοξασινη και τον αντιοξειδωτικο παραγοντα ασκορβικο οξυ για τη θεραπεια λοιμωξεων του ουροποιητικου συστηματος
JP2021521227A5 (https=)